-
1
-
-
84856223934
-
Dynamic expression of Tbx2 subfamily genes in development of the mouse reproductive system
-
Douglas NC, Heng K, Sauer MV, Papaioannou VE. Dynamic expression of Tbx2 subfamily genes in development of the mouse reproductive system. Dev Dyn 2012;241: 365-75.
-
(2012)
Dev Dyn
, vol.241
, pp. 365-375
-
-
Douglas, N.C.1
Heng, K.2
Sauer, M.V.3
Papaioannou, V.E.4
-
2
-
-
79959949912
-
Mechanisms of T-box gene function in the developing heart
-
Greulich F, Rudat C, Kispert A. Mechanisms of T-box gene function in the developing heart. Cardiovasc Res 2011;91: 212-22.
-
(2011)
Cardiovasc Res
, vol.91
, pp. 212-222
-
-
Greulich, F.1
Rudat, C.2
Kispert, A.3
-
3
-
-
78751528579
-
Role of Tbx2 in defining the territory of the pronephric nephron
-
Cho GS, Choi SC, Park EC, Han JK. Role of Tbx2 in defining the territory of the pronephric nephron. Development 2011;138: 465-74.
-
(2011)
Development
, vol.138
, pp. 465-474
-
-
Cho, G.S.1
Choi, S.C.2
Park, E.C.3
Han, J.K.4
-
4
-
-
0033764030
-
Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers
-
Jacobs JJ, Keblusek P, Robanus-Maandag E, Kristel P, Lingbeek M, Nederlof PM, et al. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers. Nat Genet 2000;26: 291-9.
-
(2000)
Nat Genet
, vol.26
, pp. 291-299
-
-
Jacobs, J.J.1
Keblusek, P.2
Robanus-Maandag, E.3
Kristel, P.4
Lingbeek, M.5
Nederlof, P.M.6
-
5
-
-
0037135545
-
The T-box repressors TBX2 and TBX3 specifically regulate the tumor suppressor gene p14ARF via a variant T-site in the initiator
-
Lingbeek ME, Jacobs JJ, van Lohuizen M. The T-box repressors TBX2 and TBX3 specifically regulate the tumor suppressor gene p14ARF via a variant T-site in the initiator. J Biol Chem 2002;277: 26120-7.
-
(2002)
J Biol Chem
, vol.277
, pp. 26120-26127
-
-
Lingbeek, M.E.1
Jacobs, J.J.2
Van Lohuizen, M.3
-
6
-
-
16844387097
-
Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas
-
Vance KW, Carreira S, Brosch G, Goding CR. Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas. Cancer Res 2005;65: 2260-8.
-
(2005)
Cancer Res
, vol.65
, pp. 2260-2268
-
-
Vance, K.W.1
Carreira, S.2
Brosch, G.3
Goding, C.R.4
-
7
-
-
77955122134
-
The retinoblastoma protein modulates Tbx2 functional specificity
-
Vance KW, Shaw HM, Rodriguez M, Ott S, Goding CR. The retinoblastoma protein modulates Tbx2 functional specificity. Mol Biol Cell 2010;21: 2770-9.
-
(2010)
Mol Biol Cell
, vol.21
, pp. 2770-2779
-
-
Vance, K.W.1
Shaw, H.M.2
Rodriguez, M.3
Ott, S.4
Goding, C.R.5
-
8
-
-
0036317876
-
High-throughput copy number analysis of 17q23 in 3520 tissue specimens by fluorescence in situ hybridization to tissue microarrays
-
Andersen CL, Monni O, Wagner U, Kononen J, Barlund M, Bucher C, et al. High-throughput copy number analysis of 17q23 in 3520 tissue specimens by fluorescence in situ hybridization to tissue microarrays. Am J Pathol 2002;161: 73-9.
-
(2002)
Am J Pathol
, vol.161
, pp. 73-79
-
-
Andersen, C.L.1
Monni, O.2
Wagner, U.3
Kononen, J.4
Barlund, M.5
Bucher, C.6
-
9
-
-
0028272478
-
Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer
-
Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, Hopwood VL, et al. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res 1994;54: 2577-81.
-
(1994)
Cancer Res
, vol.54
, pp. 2577-2581
-
-
Thalmann, G.N.1
Anezinis, P.E.2
Chang, S.M.3
Zhau, H.E.4
Kim, E.E.5
Hopwood, V.L.6
-
10
-
-
0030451767
-
Androgenrepressed phenotype in human prostate cancer
-
Zhau HY, Chang SM, Chen BQ, Wang Y, Zhang H, Kao C, et al. Androgenrepressed phenotype in human prostate cancer. Proc Natl Acad Sci U S A 1996;93: 15152-7.
-
(1996)
Proc Natl Acad Sci U S A
, vol.93
, pp. 15152-15157
-
-
Zhau, H.Y.1
Chang, S.M.2
Chen, B.Q.3
Wang, Y.4
Zhang, H.5
Kao, C.6
-
11
-
-
33750466563
-
Prostate cancer metastasis: Role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis
-
Xu J, Wang R, Xie ZH, Odero-Marah V, Pathak S, Multani A, et al. Prostate cancer metastasis: Role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis. Prostate 2006;66: 1664-73.
-
(2006)
Prostate
, vol.66
, pp. 1664-1673
-
-
Xu, J.1
Wang, R.2
Xie, Z.H.3
Odero-Marah, V.4
Pathak, S.5
Multani, A.6
-
12
-
-
47549095025
-
Epithelial to mesenchymal transition (EMT) in human prostate cancer: Lessons learned from ARCaP model
-
Zhau HE, Odero-Marah V, Lue HW, Nomura T, Wang R, Chu G, et al. Epithelial to mesenchymal transition (EMT) in human prostate cancer: Lessons learned from ARCaP model. Clin Exp Metastasis 2008;25: 601-10.
-
(2008)
Clin Exp Metastasis
, vol.25
, pp. 601-610
-
-
Zhau, H.E.1
Odero-Marah, V.2
Lue, H.W.3
Nomura, T.4
Wang, R.5
Chu, G.6
-
13
-
-
0033119141
-
E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens
-
De Marzo AM, Knudsen B, Chan-Tack K, Epstein JI. E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens. Urology 1999;53: 707-13.
-
(1999)
Urology
, vol.53
, pp. 707-713
-
-
De Marzo, A.M.1
Knudsen, B.2
Chan-Tack, K.3
Epstein, J.I.4
-
14
-
-
0031849770
-
Establishing human prostate cancer cell xenografts in bone: Induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines
-
Wu TT, Sikes RA, Cui Q, Thalmann GN, Kao C, Murphy CF, et al. Establishing human prostate cancer cell xenografts in bone: Induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines. Int J Cancer 1998;77: 887-94.
-
(1998)
Int J Cancer
, vol.77
, pp. 887-894
-
-
Wu, T.T.1
Sikes, R.A.2
Cui, Q.3
Thalmann, G.N.4
Kao, C.5
Murphy, C.F.6
-
15
-
-
84899864278
-
RANKand c-Met-mediated signal network promotes prostate cancer metastatic colonization
-
Chu GC, Zhau HE, Wang R, Rogatko A, Feng X, Zayzafoon M, et al. RANKand c-Met-mediated signal network promotes prostate cancer metastatic colonization. Endocr Relat Cancer 2014;21: 311-26.
-
(2014)
Endocr Relat Cancer
, vol.21
, pp. 311-326
-
-
Chu, G.C.1
Zhau, H.E.2
Wang, R.3
Rogatko, A.4
Feng, X.5
Zayzafoon, M.6
-
16
-
-
49149114127
-
Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells
-
Odero-Marah VA, Wang R, Chu G, Zayzafoon M, Xu J, Shi C, et al. Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells. Cell Res 2008;18: 858-70.
-
(2008)
Cell Res
, vol.18
, pp. 858-870
-
-
Odero-Marah, V.A.1
Wang, R.2
Chu, G.3
Zayzafoon, M.4
Xu, J.5
Shi, C.6
-
17
-
-
27344451557
-
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
-
Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005;310: 644-8.
-
(2005)
Science
, vol.310
, pp. 644-648
-
-
Tomlins, S.A.1
Rhodes, D.R.2
Perner, S.3
Dhanasekaran, S.M.4
Mehra, R.5
Sun, X.W.6
-
18
-
-
48749092646
-
Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms
-
Li ZG, Mathew P, Yang J, StarbuckMW, Zurita AJ, Liu J, et al. Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms. J Clin Invest 2008;118: 2697-710.
-
(2008)
J Clin Invest
, vol.118
, pp. 2697-2710
-
-
Li, Z.G.1
Mathew, P.2
Yang, J.3
Starbuck, M.W.4
Zurita, A.J.5
Liu, J.6
-
19
-
-
0035504693
-
A dominant repression domain in Tbx3 mediates transcriptional repression and cell immortalization: Relevance to mutations in Tbx3 that cause ulnar-mammary syndrome
-
Carlson H, Ota S, Campbell CE, Hurlin PJ. A dominant repression domain in Tbx3 mediates transcriptional repression and cell immortalization: Relevance to mutations in Tbx3 that cause ulnar-mammary syndrome. Hum Mol Genet 2001;10: 2403-13.
-
(2001)
Hum Mol Genet
, vol.10
, pp. 2403-2413
-
-
Carlson, H.1
Ota, S.2
Campbell, C.E.3
Hurlin, P.J.4
-
20
-
-
0041911184
-
Tbx5 is required for forelimb bud formation and continued outgrowth
-
Rallis C, Bruneau BG, Del Buono J, Seidman CE, Seidman JG, Nissim S, et al. Tbx5 is required for forelimb bud formation and continued outgrowth. Development 2003;130: 2741-51.
-
(2003)
Development
, vol.130
, pp. 2741-2751
-
-
Rallis, C.1
Bruneau, B.G.2
Del Buono, J.3
Seidman, C.E.4
Seidman, J.G.5
Nissim, S.6
-
21
-
-
0030223057
-
Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice
-
Pettaway CA, Pathak S, Greene G, Ramirez E, Wilson MR, Killion JJ, et al. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin Cancer Res 1996;2: 1627-36.
-
(1996)
Clin Cancer Res
, vol.2
, pp. 1627-1636
-
-
Pettaway, C.A.1
Pathak, S.2
Greene, G.3
Ramirez, E.4
Wilson, M.R.5
Killion, J.J.6
-
22
-
-
0021186338
-
Metastatic behavior of human tumor cell lines grown in the nude mouse
-
Kozlowski JM, Fidler IJ, Campbell D, Xu ZL, Kaighn ME, Hart IR.Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res 1984;44: 3522-9.
-
(1984)
Cancer Res
, vol.44
, pp. 3522-3529
-
-
Kozlowski, J.M.1
Fidler, I.J.2
Campbell, D.3
Xu, Z.L.4
Kaighn, M.E.5
Hart, I.R.6
-
23
-
-
0033895499
-
Suppression of primary tumor growth and the progression to metastasis with p53 adenovirus in human prostate cancer
-
Eastham JA, Grafton W, Martin CM, Williams BJ. Suppression of primary tumor growth and the progression to metastasis with p53 adenovirus in human prostate cancer. J Urol 2000;164: 814-9.
-
(2000)
J Urol
, vol.164
, pp. 814-819
-
-
Eastham, J.A.1
Grafton, W.2
Martin, C.M.3
Williams, B.J.4
-
24
-
-
0033962103
-
Markers of bone turnover for the management of patients with bone metastases from prostate cancer
-
Garnero P, Buchs N, Zekri J, Rizzoli R, Coleman RE, Delmas PD. Markers of bone turnover for the management of patients with bone metastases from prostate cancer. Br J Cancer 2000;82: 858-64.
-
(2000)
Br J Cancer
, vol.82
, pp. 858-864
-
-
Garnero, P.1
Buchs, N.2
Zekri, J.3
Rizzoli, R.4
Coleman, R.E.5
Delmas, P.D.6
-
25
-
-
21044447090
-
Prostate cancer mediates osteoclastogenesis through two different pathways
-
Inoue H, Nishimura K, Oka D, Nakai Y, Shiba M, Tokizane T, et al. Prostate cancer mediates osteoclastogenesis through two different pathways. Cancer Lett 2005;223: 121-8.
-
(2005)
Cancer Lett
, vol.223
, pp. 121-128
-
-
Inoue, H.1
Nishimura, K.2
Oka, D.3
Nakai, Y.4
Shiba, M.5
Tokizane, T.6
-
26
-
-
0035021176
-
Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone
-
Zhang J, Dai J, Qi Y, Lin DL, Smith P, Strayhorn C, et al. Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone. J Clin Invest 2001;107: 1235-44.
-
(2001)
J Clin Invest
, vol.107
, pp. 1235-1244
-
-
Zhang, J.1
Dai, J.2
Qi, Y.3
Lin, D.L.4
Smith, P.5
Strayhorn, C.6
-
27
-
-
33847729474
-
DU145 human prostate cancer cells express functional receptor activator of NFkappaB: New insights in the prostate cancer bone metastasis process
-
Mori K, Le Goff B, Charrier C, Battaglia S, Heymann D, Redini F. DU145 human prostate cancer cells express functional receptor activator of NFkappaB: New insights in the prostate cancer bone metastasis process. Bone 2007;40: 981-90.
-
(2007)
Bone
, vol.40
, pp. 981-990
-
-
Mori, K.1
Le Goff, B.2
Charrier, C.3
Battaglia, S.4
Heymann, D.5
Redini, F.6
-
28
-
-
1542317670
-
Intraosseous growth of human prostate cancer in implanted adult human bone: Relationship of prostate cancer cells to osteoclasts in osteoblastic metastatic lesions
-
Yonou H, Ochiai A, Goya M, Kanomata N, Hokama S, Morozumi M, et al. Intraosseous growth of human prostate cancer in implanted adult human bone: Relationship of prostate cancer cells to osteoclasts in osteoblastic metastatic lesions. Prostate 2004;58: 406-13.
-
(2004)
Prostate
, vol.58
, pp. 406-413
-
-
Yonou, H.1
Ochiai, A.2
Goya, M.3
Kanomata, N.4
Hokama, S.5
Morozumi, M.6
-
29
-
-
7444256731
-
Analysis of Wnt gene expression in prostate cancer: Mutual inhibition by WNT11 and the androgen receptor
-
Zhu H, Mazor M, Kawano Y, Walker MM, Leung HY, Armstrong K, et al. Analysis of Wnt gene expression in prostate cancer: Mutual inhibition by WNT11 and the androgen receptor. Cancer Res 2004;64: 7918-26.
-
(2004)
Cancer Res
, vol.64
, pp. 7918-7926
-
-
Zhu, H.1
Mazor, M.2
Kawano, Y.3
Walker, M.M.4
Leung, H.Y.5
Armstrong, K.6
-
31
-
-
79954461450
-
Expression profile of WNT molecules in prostate cancer and its regulation by aminobisphosphonates
-
Thiele S, Rauner M, Goettsch C, Rachner TD, Benad P, Fuessel S, et al. Expression profile of WNT molecules in prostate cancer and its regulation by aminobisphosphonates. J Cell Biochem 2011;112: 1593-600.
-
(2011)
J Cell Biochem
, vol.112
, pp. 1593-1600
-
-
Thiele, S.1
Rauner, M.2
Goettsch, C.3
Rachner, T.D.4
Benad, P.5
Fuessel, S.6
-
32
-
-
33646533771
-
Roles and regulation of Wnt signaling and beta-catenin in prostate cancer
-
Verras M, Sun Z. Roles and regulation of Wnt signaling and beta-catenin in prostate cancer. Cancer Lett 2006;237: 22-32.
-
(2006)
Cancer Lett
, vol.237
, pp. 22-32
-
-
Verras, M.1
Sun, Z.2
-
33
-
-
34047265189
-
Inactivation of Apc in the mouse prostate causes prostate carcinoma
-
Bruxvoort KJ, Charbonneau HM, Giambernardi TA, Goolsby JC, Qian CN, Zylstra CR, et al. Inactivation of Apc in the mouse prostate causes prostate carcinoma. Cancer Res 2007;67: 2490-6.
-
(2007)
Cancer Res
, vol.67
, pp. 2490-2496
-
-
Bruxvoort, K.J.1
Charbonneau, H.M.2
Giambernardi, T.A.3
Goolsby, J.C.4
Qian, C.N.5
Zylstra, C.R.6
-
34
-
-
79955479314
-
Wnt/beta-catenin activation promotes prostate tumor progression in a mouse model
-
Yu X, Wang Y, DeGraff DJ, Wills ML, Matusik RJ. Wnt/beta-catenin activation promotes prostate tumor progression in a mouse model. Oncogene 2011;30: 1868-79.
-
(2011)
Oncogene
, vol.30
, pp. 1868-1879
-
-
Yu, X.1
Wang, Y.2
DeGraff, D.J.3
Wills, M.L.4
Matusik, R.J.5
-
35
-
-
67649948804
-
WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics
-
Bisson I, Prowse DM. WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics. Cell Res 2009;19: 683-97.
-
(2009)
Cell Res
, vol.19
, pp. 683-697
-
-
Bisson, I.1
Prowse, D.M.2
-
36
-
-
84930225081
-
Integrative clinical genomics of advanced prostate cancer
-
Robinson D, Van Allen EM, Wu YM, Schultz N, Lonigro RJ, Mosquera JM, et al. Integrative clinical genomics of advanced prostate cancer. Cell 2015;161: 1215-28.
-
(2015)
Cell
, vol.161
, pp. 1215-1228
-
-
Robinson, D.1
Van Allen, E.M.2
Wu, Y.M.3
Schultz, N.4
Lonigro, R.J.5
Mosquera, J.M.6
-
37
-
-
24744439747
-
Prostate cancer cells promote osteoblastic bone metastases through Wnts
-
Hall CL, Bafico A, Dai J, Aaronson SA, Keller ET. Prostate cancer cells promote osteoblastic bone metastases through Wnts. Cancer Res 2005; 65: 7554-60.
-
(2005)
Cancer Res
, vol.65
, pp. 7554-7560
-
-
Hall, C.L.1
Bafico, A.2
Dai, J.3
Aaronson, S.A.4
Keller, E.T.5
-
38
-
-
48649090754
-
Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms
-
Dai J, Hall CL, Escara-Wilke J, Mizokami A, Keller JM, Keller ET. Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms. Cancer Res 2008;68: 5785-94.
-
(2008)
Cancer Res
, vol.68
, pp. 5785-5794
-
-
Dai, J.1
Hall, C.L.2
Escara-Wilke, J.3
Mizokami, A.4
Keller, J.M.5
Keller, E.T.6
-
39
-
-
58149215849
-
Prostate tumor progression is mediated by a paracrine TGF-beta/Wnt3a signaling axis
-
Li X, Placencio V, Iturregui JM, Uwamariya C, Sharif-Afshar AR, Koyama T, et al. Prostate tumor progression is mediated by a paracrine TGF-beta/Wnt3a signaling axis. Oncogene 2008;27: 7118-30.
-
(2008)
Oncogene
, vol.27
, pp. 7118-7130
-
-
Li, X.1
Placencio, V.2
Iturregui, J.M.3
Uwamariya, C.4
Sharif-Afshar, A.R.5
Koyama, T.6
-
40
-
-
33644914996
-
Differential inhibition of Wnt-3a by Sfrp-1, Sfrp-2, and Sfrp-3
-
Galli LM, Barnes T, Cheng T, Acosta L, Anglade A, Willert K, et al. Differential inhibition of Wnt-3a by Sfrp-1, Sfrp-2, and Sfrp-3. Dev Dyn 2006;235: 681-90.
-
(2006)
Dev Dyn
, vol.235
, pp. 681-690
-
-
Galli, L.M.1
Barnes, T.2
Cheng, T.3
Acosta, L.4
Anglade, A.5
Willert, K.6
-
41
-
-
84883190661
-
WNT/beta-catenin signaling induces IL-1beta expression by alveolar epithelial cells in pulmonary fibrosis
-
Aumiller V, Balsara N, Wilhelm J, Gunther A, Konigshoff M. WNT/beta-catenin signaling induces IL-1beta expression by alveolar epithelial cells in pulmonary fibrosis. Am J Respir Cell Mol Biol 2013; 49: 96-104.
-
(2013)
Am J Respir Cell Mol Biol
, vol.49
, pp. 96-104
-
-
Aumiller, V.1
Balsara, N.2
Wilhelm, J.3
Gunther, A.4
Konigshoff, M.5
-
42
-
-
16344365813
-
The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: Results from cancer and leukemia group B 9480
-
George DJ, Halabi S, Shepard TF, Sanford B, Vogelzang NJ, Small EJ, et al. The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: Results from cancer and leukemia group B 9480. Clin Cancer Res 2005;11: 1815-20.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 1815-1820
-
-
George, D.J.1
Halabi, S.2
Shepard, T.F.3
Sanford, B.4
Vogelzang, N.J.5
Small, E.J.6
-
43
-
-
84916883963
-
Targeting IL-6 and RANKL signaling inhibits prostate cancer growth in bone
-
Zheng Y, Basel D, Chow SO, Fong-Yee C, Kim S, Buttgereit F, et al. Targeting IL-6 and RANKL signaling inhibits prostate cancer growth in bone. Clin Exp Metastasis 2014;31: 921-33.
-
(2014)
Clin Exp Metastasis
, vol.31
, pp. 921-933
-
-
Zheng, Y.1
Basel, D.2
Chow, S.O.3
Fong-Yee, C.4
Kim, S.5
Buttgereit, F.6
-
44
-
-
33847268280
-
Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration
-
Wu B, Crampton SP, Hughes CC. Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity 2007;26: 227-39.
-
(2007)
Immunity
, vol.26
, pp. 227-239
-
-
Wu, B.1
Crampton, S.P.2
Hughes, C.C.3
-
45
-
-
0037005993
-
Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis
-
Nemeth JA, Yousif R, Herzog M, Che M, Upadhyay J, Shekarriz B, et al. Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis. J Natl Cancer Inst 2002;94: 17-25.
-
(2002)
J Natl Cancer Inst
, vol.94
, pp. 17-25
-
-
Nemeth, J.A.1
Yousif, R.2
Herzog, M.3
Che, M.4
Upadhyay, J.5
Shekarriz, B.6
-
46
-
-
0032548966
-
Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension
-
Gohji K, Fujimoto N, Hara I, Fujii A, Gotoh A, Okada H, et al. Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension. Int J Cancer 1998; 79: 96-101.
-
(1998)
Int J Cancer
, vol.79
, pp. 96-101
-
-
Gohji, K.1
Fujimoto, N.2
Hara, I.3
Fujii, A.4
Gotoh, A.5
Okada, H.6
-
47
-
-
0032054579
-
Increased incidence of matrix metalloproteinases in urine of cancer patients
-
Moses MA, Wiederschain D, Loughlin KR, Zurakowski D, Lamb CC, Freeman MR. Increased incidence of matrix metalloproteinases in urine of cancer patients. Cancer Res 1998;58: 1395-9.
-
(1998)
Cancer Res
, vol.58
, pp. 1395-1399
-
-
Moses, M.A.1
Wiederschain, D.2
Loughlin, K.R.3
Zurakowski, D.4
Lamb, C.C.5
Freeman, M.R.6
-
48
-
-
0033567964
-
Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas
-
Kossakowska AE, Edwards DR, Prusinkiewicz C, Zhang MC, Guo D, Urbanski SJ, et al. Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas. Blood 1999;94: 2080-9.
-
(1999)
Blood
, vol.94
, pp. 2080-2089
-
-
Kossakowska, A.E.1
Edwards, D.R.2
Prusinkiewicz, C.3
Zhang, M.C.4
Guo, D.5
Urbanski, S.J.6
-
49
-
-
84859116916
-
Genomic targets of Brachyury (T) in differentiating mouse embryonic stem cells
-
Evans AL, Faial T, Gilchrist MJ, Down T, Vallier L, Pedersen RA, et al. Genomic targets of Brachyury (T) in differentiating mouse embryonic stem cells. PLoS One 2012;7: E33346.
-
(2012)
PLoS One
, vol.7
, pp. e33346
-
-
Evans, A.L.1
Faial, T.2
Gilchrist, M.J.3
Down, T.4
Vallier, L.5
Pedersen, R.A.6
-
50
-
-
77949766590
-
The T-box transcription factor Tbx2: Its role in development and possible implication in cancer
-
Abrahams A, Parker MI, Prince S. The T-box transcription factor Tbx2: Its role in development and possible implication in cancer. IUBMB Life 2010;62: 92-102.
-
(2010)
IUBMB Life
, vol.62
, pp. 92-102
-
-
Abrahams, A.1
Parker, M.I.2
Prince, S.3
|